Diagnostic utility of different MRI and MR angiography measures in Fabry disease

被引:71
作者
Fellgiebel, A. [3 ]
Keller, I. [1 ,3 ]
Marin, D. [3 ]
Mueller, M. J. [3 ]
Schermuly, I. [3 ]
Yakushev, I. [3 ]
Albrecht, J. [3 ]
Bellhaeuser, H. [3 ]
Kinateder, M. [3 ]
Beck, M. [2 ]
Stoeter, P. [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Inst Neuroradiol, D-6500 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Childrens Hosp, D-6500 Mainz, Germany
[3] Johannes Gutenberg Univ Mainz, Dept Psychiat, D-6500 Mainz, Germany
关键词
CEREBRAL-BLOOD-FLOW; WHITE-MATTER LESIONS; ENZYME REPLACEMENT; CLINICAL-MANIFESTATIONS; HYPERPERFUSION; VASCULOPATHY; PREVALENCE; REVERSAL; STORAGE;
D O I
10.1212/01.wnl.0000338566.54190.8a
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Neurologic hallmarks of Fabry disease (FD) include small fiber neuropathy as well as cerebral micro- and macroangiopathy with premature stroke. Cranial MRI shows progressive white matter lesions (WML) at an early age, increased signal intensity in the pulvinar, and tortuosity and dilatation of the larger vessels. To unravel the most promising imaging tool for the detection of CNS involvement in FD we compared the diagnostic utility of the different MR imaging findings. Methods: Twenty-five clinically affected patients with FD ( age 36.5 +/- 11.0) and 20 age-matched controls were investigated by structural MRI, MR angiography, and diffusion tensor imaging (DTI). Individual WML volumes, global mean diffusivity ( MD), and mean cerebral artery diameters were determined. Results: Using receiver operating characteristic analyses, enlarged diameters of the following cerebral arteries significantly separated patients with FD from controls: middle cerebral artery: area under curve (AUC) = 0.75, p = 0.005; posterior cerebral artery: AUC = 0.69, p = 0.041; carotid artery: 0.69, p = 0.041; basilar artery: AUC = 0.96, p < 0.0005. A total of 87% of the individuals were correctly classified by basilar artery diameters (sensitivity 95%, specificity 83%). WML volumes and global MD values did not significantly separate patients from controls. Conclusions: With an accuracy of 87%, basilar artery diameters were superior to all other MR measures for separating patients with Fabry disease (FD) from controls. Future studies should adopt basilar artery measurements for early detection and monitoring of brain involvement in FD. Moreover, further investigations should reveal if the dilated vasculopathy in FD could be a screening marker to detect FD in a cohort of other cerebrovascular diseases, especially in cryptogenic stroke. Neurology (R) 2009; 72: 63-68
引用
收藏
页码:63 / 68
页数:6
相关论文
共 24 条
  • [1] Voxel based analyses of diffusion tensor imaging in Fabry disease
    Albrecht, J.
    Dellani, P. R.
    Mueller, M. J.
    Schermuly, I.
    Beck, M.
    Stoeter, P.
    Gerhard, A.
    Fellgiebel, A.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (09) : 964 - 969
  • [2] MEASUREMENT OF INTERNAL CAROTID-ARTERY STENOSIS FROM SOURCE MR ANGIOGRAMS
    ANDERSON, CM
    LEE, RE
    LEVIN, DL
    ALONSO, SD
    SALONER, D
    [J]. RADIOLOGY, 1994, 193 (01) : 219 - 226
  • [3] Fabry disease: overall effects of agalsidase alfa treatment
    Beck, M
    Ricci, R
    Widmer, U
    Dehout, F
    de Lorenzo, AG
    Kampmann, C
    Linhart, A
    Sunder-Plassmann, G
    Houge, G
    Ramaswami, U
    Gal, A
    Mehta, A
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 (12) : 838 - 844
  • [4] High total cerebral blood flow is associated with a decrease of white matter lesions
    Bisschops, RHC
    van der Graaf, Y
    Mali, WPTM
    van der Grond, J
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 (12) : 1481 - 1485
  • [5] Quantitative analysis of cerebral vasculopathy in patients with Fabry disease
    Crutchfield, KE
    Patronas, NJ
    Dambrosia, JM
    Frei, KP
    Banerjee, TK
    Barton, NW
    Schiffmann, R
    [J]. NEUROLOGY, 1998, 50 (06) : 1746 - 1749
  • [6] Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy
    Desnick, RJ
    Brady, R
    Barranger, J
    Collins, AJ
    Germain, DP
    Goldman, M
    Grabowski, G
    Packman, S
    Wilcox, WR
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (04) : 338 - 346
  • [7] White matter lesion severity in male and female patients with Fabry disease
    Fellgiebel, A
    Müller, MJ
    Mazanek, M
    Baron, K
    Beck, M
    Stoeter, P
    [J]. NEUROLOGY, 2005, 65 (04) : 600 - 602
  • [8] CNS manifestations of Fabry's disease
    Fellgiebel, Andreas
    Mueller, Matthias J.
    Ginsberg, Lionel
    [J]. LANCET NEUROLOGY, 2006, 5 (09) : 791 - 795
  • [9] Pattern of microstructural brain tissue alterations in Fabry disease -: A diffusion-tensor imaging study
    Fellgiebel, Andreas
    Mazanek, Martin
    Whybra, Catharina
    Beck, Michael
    Hartung, Ralf
    Mueller, Kay-Maria
    Scheurich, Armin
    Dellani, Paulo R.
    Stoeter, Peter
    Mueller, Matthias J.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 (06) : 780 - 787
  • [10] The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease a cross-sectional study of a large cohort of clinically affected heterozygous women
    Gupta, S
    Ries, M
    Kotsopoulos, S
    Schiffmann, R
    [J]. MEDICINE, 2005, 84 (05) : 261 - 268